Published in Science on August 08, 1997
Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis (SLAM-2) | NCT02737202
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol (2004) 9.71
The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J (2008) 6.32
Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med (2008) 5.15
TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med (2008) 4.76
TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev (2001) 4.68
Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A (2000) 4.30
PEComas: the past, the present and the future. Virchows Arch (2007) 3.93
Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol (2013) 3.49
Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet (2000) 3.44
Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev (2007) 3.41
Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest (1999) 3.38
Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J Cell Biol (2006) 3.33
Somatic mutation, genomic variation, and neurological disease. Science (2013) 2.72
Autophagy in malignant transformation and cancer progression. EMBO J (2015) 2.67
Regulation of mTORC1 by amino acids. Trends Cell Biol (2014) 2.64
Signaling by target of rapamycin proteins in cell growth control. Microbiol Mol Biol Rev (2005) 2.56
The tuberous sclerosis complex. Ann N Y Acad Sci (2010) 2.51
Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med (2012) 2.38
A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice. Proc Natl Acad Sci U S A (2001) 2.35
Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet (1999) 2.26
Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol (2013) 2.22
The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis. Oncogene (2009) 2.14
Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet (1998) 2.13
Protein interactome reveals converging molecular pathways among autism disorders. Sci Transl Med (2011) 2.04
Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Hum Genet (2007) 1.94
Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis Model Mech (2009) 1.87
Lymphangioleiomyomatosis - a wolf in sheep's clothing. J Clin Invest (2012) 1.87
Autism and tuberous sclerosis. J Autism Dev Disord (1998) 1.84
Reversing neurodevelopmental disorders in adults. Neuron (2008) 1.80
Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum Mol Genet (2009) 1.79
Rheb is essential for murine development. Mol Cell Biol (2011) 1.76
Lymphangioleiomyomatosis: what do we know and what are we looking for? Eur Respir Rev (2011) 1.73
Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes. BMC Genomics (2006) 1.73
Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation. J Med Genet (1999) 1.71
Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol (1997) 1.63
Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients. Am J Hum Genet (1998) 1.61
Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc Natl Acad Sci U S A (1998) 1.59
Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proc Natl Acad Sci U S A (2011) 1.58
Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures. Am J Pathol (2003) 1.57
Regulation of mTORC1 by PI3K signaling. Trends Cell Biol (2015) 1.54
Malformations of cortical development and epilepsy. Dialogues Clin Neurosci (2008) 1.53
Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia (2007) 1.48
Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans. Am J Respir Cell Mol Biol (2006) 1.47
Biphasic response of pancreatic beta-cell mass to ablation of tuberous sclerosis complex 2 in mice. Mol Cell Biol (2008) 1.46
Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders. Trends Mol Med (2010) 1.46
Role of the Tsc1-Tsc2 complex in signaling and transport across the cell membrane in the fission yeast Schizosaccharomyces pombe. Genetics (2002) 1.43
Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment. Hum Mol Genet (2009) 1.40
Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J Hum Genet (2001) 1.39
Biallelic TSC gene inactivation in tuberous sclerosis complex. Neurology (2010) 1.39
High rate of mosaicism in tuberous sclerosis complex. Am J Hum Genet (1999) 1.38
Pushing the envelope in the mTOR pathway: the second generation of inhibitors. Mol Cancer Ther (2011) 1.38
PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects. Cell Cycle (2009) 1.38
From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis. J Intellect Disabil Res (2009) 1.37
Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice. Epilepsia (2011) 1.36
Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes. Best Pract Res Clin Endocrinol Metab (2010) 1.35
Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex. Hum Genet (2010) 1.34
PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. Brain (2015) 1.33
Ras and Rap signaling in synaptic plasticity and mental disorders. Neuroscientist (2010) 1.29
Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex. Neurology (2011) 1.28
Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc Natl Acad Sci U S A (1998) 1.28
Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics (2011) 1.27
Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer. Cancer Metastasis Rev (2009) 1.26
Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann Neurol (2008) 1.26
Metabolic regulation of neuronal plasticity by the energy sensor AMPK. PLoS One (2010) 1.25
mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies. Aging Cell (2013) 1.24
The pathogenesis and imaging of the tuberous sclerosis complex. Pediatr Radiol (2008) 1.20
Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models. BMC Pharmacol (2009) 1.20
Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am J Hum Genet (1998) 1.19
Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis. Chest (2009) 1.19
Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver. J Clin Invest (2010) 1.17
New insights into the tumor suppression function of P27(kip1) Proc Natl Acad Sci U S A (1998) 1.17
Mechanism-based treatment in tuberous sclerosis complex. Pediatr Neurol (2013) 1.17
Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis. Am J Respir Crit Care Med (2010) 1.17
Biology and treatment of metastatic gastrointestinal neuroendocrine tumors. Gastrointest Cancer Res (2008) 1.16
Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Nat Commun (2012) 1.16
Deconvoluting mTOR biology. Cell Cycle (2012) 1.16
Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology (2011) 1.15
Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors. J Transl Med (2010) 1.15
Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients. PLoS One (2013) 1.15
Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond. Pediatr Nephrol (2005) 1.15
Our changing view of the genomic landscape of cancer. J Pathol (2010) 1.13
Germ-line mosaicism in tuberous sclerosis: how common? Am J Hum Genet (1999) 1.12
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model. BMC Dermatol (2008) 1.12
Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol (2009) 1.12
Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas. Br J Cancer (2001) 1.11
Genetics and molecular biology of tuberous sclerosis complex. Curr Genomics (2008) 1.08
The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms. Am J Pathol (2001) 1.08
Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing. PLoS Genet (2015) 1.07
Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis. EMBO Mol Med (2011) 1.07
The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex. Hum Mol Genet (2012) 1.06
Hormone receptor expression in renal angiomyolipoma: clinicopathologic correlation. Urology (2008) 1.05
Molecular and clinical analyses of 84 patients with tuberous sclerosis complex. BMC Med Genet (2006) 1.05
Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin. Hum Mol Genet (2011) 1.05
Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses. Front Mol Neurosci (2013) 1.04
Lessons learned from studying syndromic autism spectrum disorders. Nat Neurosci (2016) 1.04
Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biomed J (2013) 1.03
Multiplex ligation-depending probe amplification is not suitable for detection of low-grade mosaicism. Eur J Hum Genet (2011) 1.03
Cellular and synaptic network defects in autism. Curr Opin Neurobiol (2012) 1.02
Renal and liver tumors in Tsc2(+/-) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Mol Cancer Ther (2009) 1.02
Genotype and cognitive phenotype of patients with tuberous sclerosis complex. Eur J Hum Genet (2011) 1.02
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (1998) 60.62
An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom (1994) 45.51
Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol (2001) 28.01
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
An STS-based map of the human genome. Science (1995) 17.72
Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol (1999) 12.42
Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A (2006) 10.24
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest (2000) 9.51
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation (1996) 9.00
Construction of a GT polymorphism map of human 9q. Genomics (1992) 8.92
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA (2001) 8.80
Report of the Committee on the Genetic Constitution of Chromosomes 1 and 2. Cytogenet Cell Genet (1985) 7.70
Characterization of a panel of highly variable minisatellites cloned from human DNA. Ann Hum Genet (1987) 7.58
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest (1999) 7.40
Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil (2012) 7.24
Protein sequencing by tandem mass spectrometry. Proc Natl Acad Sci U S A (1986) 7.09
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res (2001) 6.93
An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem (2001) 6.90
Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet (1997) 6.85
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell (1998) 6.58
Electron microscopical reconstruction of the anterior sensory anatomy of the nematode Caenorhabditis elegans.?2UU. J Comp Neurol (1975) 6.58
Guidelines for human gene nomenclature (1997). HUGO Nomenclature Committee. Genomics (1997) 6.44
Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell (1996) 5.99
A global profile of germline gene expression in C. elegans. Mol Cell (2000) 5.97
Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet (1993) 5.70
Nonmuscle actin-binding proteins. Annu Rev Cell Biol (1985) 5.46
Mus81-Eme1 are essential components of a Holliday junction resolvase. Cell (2001) 5.37
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst (1995) 5.35
A combined PET/CT scanner for clinical oncology. J Nucl Med (2000) 4.99
Dynamic molecular combing: stretching the whole human genome for high-resolution studies. Science (1997) 4.86
Chemotaxis by the nematode Caenorhabditis elegans: identification of attractants and analysis of the response by use of mutants. Proc Natl Acad Sci U S A (1973) 4.76
Clinical features and natural history of von Hippel-Lindau disease. Q J Med (1990) 4.71
The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil (2014) 4.69
A subset of TAF(II)s are integral components of the SAGA complex required for nucleosome acetylation and transcriptional stimulation. Cell (1998) 4.66
Actin-binding protein requirement for cortical stability and efficient locomotion. Science (1992) 4.66
Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol (2001) 4.63
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet (2007) 4.62
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. Blood (2000) 4.37
Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A (2000) 4.30
Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science (1997) 4.19
Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A (1997) 4.11
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut (2004) 4.06
Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falciparum. Lancet (1989) 3.96
Fertilization and sperm competition in the nematode Caenorhabditis elegans. Dev Biol (1979) 3.78
Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature (1998) 3.77
Babies sleeping with parents: case-control study of factors influencing the risk of the sudden infant death syndrome. CESDI SUDI research group. BMJ (1999) 3.76
Protein identification at the low femtomole level from silver-stained gels using a new fritless electrospray interface for liquid chromatography-microspray and nanospray mass spectrometry. Anal Biochem (1998) 3.76
Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring. J Cell Biol (1990) 3.76
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A (1992) 3.72
An investigation into the effectiveness of an early intervention method for delayed language development in young children. Int J Lang Commun Disord (2000) 3.68
Improving the repeat prescribing process in a busy general practice. A study using continuous quality improvement methodology. Qual Health Care (1999) 3.61
Von Hippel-Lindau disease: a genetic study. J Med Genet (1991) 3.61
Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet (1998) 3.54
Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology (2001) 3.52
Earliest Homo. Nature (1992) 3.52
The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis (2008) 3.52
What do we know about how to do audit and feedback? Pitfalls in applying evidence from a systematic review. BMC Health Serv Res (2005) 3.51
Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature (1986) 3.50
TRAPP, a highly conserved novel complex on the cis-Golgi that mediates vesicle docking and fusion. EMBO J (1998) 3.49
The Uterine Mucosa in Menstruation and Pregnancy; the Action of the Chorionic Cells and the Function of the Decidua: Structure of the Uterine Mucosa and the Cause of the Opening-up of the Vessels during Menstruation. Proc R Soc Med (1911) 3.46
Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet (2000) 3.44
Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet (2000) 3.42
Separation of chromosomal DNA molecules from C.albicans by pulsed field gel electrophoresis. Nucleic Acids Res (1986) 3.41
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41
Human chromosome 19 and related regions in mouse: conservative and lineage-specific evolution. Science (2001) 3.39
Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest (1999) 3.38
Adenocarcinoma of colon differentiating as dome epithelium of gut-associated lymphoid tissue. Histopathology (2000) 3.36
Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet (1999) 3.32
Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: the identification of malignant epithelioid angiomyolipoma. Am J Surg Pathol (1998) 3.31
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet (1998) 3.28
Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut (2010) 3.22
Systematic cloning of human minisatellites from ordered array charomid libraries. Genomics (1990) 3.21
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med (2000) 3.16
Relationship between tumour size and uptake of radiolabelled anti-CEA in a colon tumour xenograft. Eur J Nucl Med (1987) 3.16
Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med (1995) 3.13
The AEtiology of Eclampsia and Albuminuria and their Relation to Accidental Haemorrhage: (An Anatomical and Experimental Investigation.). Proc R Soc Med (1914) 3.13
Morphology of sporadic colorectal cancer with DNA replication errors. Gut (1998) 3.11
Discrimination of human macrophages and dendritic cells by means of monoclonal antibodies. Scand J Immunol (1986) 3.11
Direct analysis and identification of proteins in mixtures by LC/MS/MS and database searching at the low-femtomole level. Anal Chem (1997) 3.09
Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell (1995) 3.08
Performance evaluation of the microPET P4: a PET system dedicated to animal imaging. Phys Med Biol (2001) 3.07
Coronin promotes the rapid assembly and cross-linking of actin filaments and may link the actin and microtubule cytoskeletons in yeast. J Cell Biol (1999) 3.03
Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics (2001) 3.02
Implication of a novel multiprotein Dam1p complex in outer kinetochore function. J Cell Biol (2001) 2.98
Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J Clin Invest (1981) 2.97
Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet (1987) 2.95